MedTrace Logo

Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia

NCT00005619 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2011-02-21

No results posted yet for this study

Summary

RATIONALE: Diagnostic procedures that detect residual disease may predict disease relapse in patients who have hairy cell leukemia.

PURPOSE: Diagnostic trial to determine the effectiveness of analyzing blood and bone marrow to detect residual disease in patients who have previously treated hairy cell leukemia.

Conditions

Interventions

GENETIC

polymerase chain reaction

OTHER

flow cytometry

OTHER

immunohistochemistry staining method

Sponsors & Collaborators

Principal Investigators

  • Loann C. Peterson, MD · Robert H. Lurie Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-02-29
Primary Completion
2001-08-31
Completion
2001-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005619 on ClinicalTrials.gov